OPERON ELEVATEPLUS | UKCA MARKING FOR MEDICAL DEVICES
UKCA Marking Consultants & UK Responsible Person Services in Germany
Operon Strategist offers comprehensive UKCA and MHRA regulatory consulting for medical device manufacturers in Germany, guiding you through device classification, conformity assessment, documentation preparation, UK Responsible Person (UKRP) setup, and successful UK registration, simplifying your cross-border route to compliance.
Take the next step
Operon ElevatePlus
UKCA Marking for Medical Devices Service Portfolio
UKCA Regulatory Strategy & Classification
Determine device risk class under UK MDR 2002
Assess conformity assessment routes depending on device type and risk
Technical Documentation Preparation
Prepare UKCA-aligned technical file
Evidence of safety, performance, and conformity requirements
Gap analysis against current CE technical files
MHRA Registration & Application Support
Complete support for MHRA device registration
Submission through the UK medical devices information system (MDIS)
Handling queries and compliance correspondence
UK Responsible Person (UKRP) Assistance
Appointment of UKRP for non-UK manufacturers
UKRP documentation and ongoing regulatory liaison
Conformity Assessment & UK Approved Body Support
Coordinate with UK Approved Bodies for assessment (required for higher-risk devices)
Audit readiness and conformity evidence support
Post-Approval Support & Ongoing Compliance
Post-market surveillance planning
Labeling updates and regulatory compliance monitoring
What Sets Us Apart
Global exposure, structured thinking, and execution-ready expertise
12+ Years of Global Regulatory Experience
200+ Successful Certifications & Registrations
Expert Support Across UK, EU, India & Other Markets
End-to-End Comprehensive UKCA Marking & MHRA Solutions
UKCA Marking & MHRA registration – we support German medical device manufacturers in achieving UKCA Marking and MHRA registration through a structured conformity and regulatory alignment approach. Our services include device classification, definition of the appropriate conformity pathway—including navigating the latest UK reliance routes for CE-marked devices—and preparation of technical documentation aligned with UK MDR 2002, enabling compliant and confident access to the UK market.
Operon UKCA Marking for Medical Devices Advantage
Complete regulatory support for achieving UKCA (UK Conformity Assessed) compliance and MHRA device registration, enabling market access in Great Britain
End-to-End UKCA Marking Support
Technical Documentation & MHRA Filing Expertise
Regulatory Strategy Aligned with UK MDR 2002
UK Responsible Person (UKRP) Support for Non-UK Manufacturers
You Might Also Be Interested in
frequently asked questions
What is the process for obtaining CE marking for medical devices under the EU MDR?
The EU MDR CE marking process requires determining your device’s exact risk class (Class I, IIa, IIb, or III), establishing an ISO 13485 Quality Management System, compiling robust Technical Documentation (including a Clinical Evaluation Report), and passing a rigorous conformity assessment conducted by a European Notified Body.
Are European Authorized Representative (EC Rep) services mandatory?
Yes, if your medical device manufacturing facility is located outside of the European Union, you are legally required to appoint a European Authorized Representative. We provide dedicated EC Rep services to hold your Technical Documentation, register your products in EUDAMED, and act as your official regulatory liaison with European Competent Authorities.
Do you provide CE marking consulting for software as a medical device (SaMD)?
Absolutely. Our CE marking consultants specialize in regulatory compliance for medical software, digital health applications, and AI/ML algorithms. We ensure your SaMD meets the stringent software lifecycle (IEC 62304), clinical evaluation, and cybersecurity requirements mandated by the EU MDR and IVDR.
How can an expert CE marking consultant accelerate my European market entry?
Navigating Notified Body bottlenecks is currently one of the biggest challenges in Europe. An experienced CE marking consultant accelerates your timeline by ensuring your Technical Documentation is completely audit-ready on the first submission, selecting the most efficient conformity assessment route, and handling direct communications with Notified Bodies to prevent costly review delays.
frequently asked questions
Do German medical device manufacturers need a UKCA mark, or is the CE mark still accepted in the UK?
The MHRA currently continues to recognize valid EU CE marks for the Great Britain market, and recent 2026 proposals point toward indefinite recognition for EU MDR-compliant devices. However, regardless of whether you use a CE mark or transition to a UKCA mark, you are still legally required to register your medical devices directly with the MHRA and appoint a UK representative to sell in the UK.
What is a UK Responsible Person (UKRP) and do we need one?
Yes. Because your manufacturing facility is located outside of the UK, you are legally required to appoint a UK Responsible Person (UKRP). The UKRP must have a physical address in the UK and acts as your official regulatory liaison. They assume legal responsibility for registering your medical devices with the MHRA and maintaining access to your technical documentation for UK authorities.
How long does MHRA medical device registration take?
Once your technical file is compliant and your UKRP is officially appointed, the MHRA registration process typically takes a few weeks, provided all submitted data is accurate. Delays usually happen due to incomplete documentation, which is why our consultants review your technical files thoroughly before submission.
How does Operon Strategist assist with UK market entry?
We provide complete regulatory support for manufacturers expanding into Great Britain. Our consultants handle device classification under the UK MDR 2002, perform gap analyses between your existing EU MDR technical files and UK requirements, assist in setting up your UKRP, and execute the final MHRA registration to ensure smooth market access.